PUBLISHER: The Business Research Company | PRODUCT CODE: 1942851
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942851
Fibrin sealants, also called fibrin glues or tissue adhesives, are medical products used to support blood clotting and promote tissue healing. Made from fibrinogen and thrombin-proteins involved in natural clot formation-they are commonly used in surgery to control bleeding in delicate areas where stitches or cauterization may not be sufficient.
The primary types in the fibrin sealants market include liquid, patch, and powder formulations. Liquid fibrin sealants contain fibrinogen and thrombin, which combine to form a fibrin clot when applied. These products are used during surgical procedures to control bleeding and enhance tissue bonding and can be administered through methods such as dripping or spraying for accurate placement. The technologies include autologous donation, viral inactivation, recombinant production, and others. The applications span general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, transplant surgery, and others, and the end users include hospitals, ambulatory surgical centers, and other healthcare facilities.
Tariffs have influenced the fibrin sealants market by increasing the cost of imported raw materials and advanced production equipment, including recombinant protein production systems. Segments such as recombinant and synthetic sealants are particularly impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased production costs and potential delays in supply. On the positive side, tariffs encourage local production, investment in domestic manufacturing facilities, and innovation in cost-effective sealant solutions.
The fibrin sealants market research report is one of a series of new reports from The Business Research Company that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The fibrin sealants market size has grown strongly in recent years. It will grow from $1.17 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to limited availability of recombinant and synthetic sealants, reliance on autologous and bovine-derived sealants, increasing surgical procedures, rising awareness about hemostasis, adoption of fibrin sealants in general surgeries.
The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to advancements in recombinant fibrin production, growth in minimally invasive and robotic surgeries, increasing demand in cardiovascular and orthopedic procedures, rising regulatory approvals and quality certifications, development of bioabsorbable and multifunctional sealants. Major trends in the forecast period include rising adoption of fibrin sealants in minimally invasive surgeries, increasing use of recombinant and synthetic sealants, expansion of orthopedic and cardiovascular surgeries, growing focus on blood conservation and hemostasis, rising preference for bioabsorbable and patch-based sealants.
The increasing number of cosmetic surgeries is increasingly supporting the expansion of the fibrin sealants market going forward. Cosmetic surgeries are medical procedures primarily performed to enhance or modify physical appearance. The growing volume of cosmetic surgeries is linked to societal emphasis on aesthetics, advancements in surgical techniques, and increased availability of minimally invasive procedures. Fibrin sealants assist cosmetic surgeries by promoting faster wound healing, minimizing bleeding, reducing scarring, and improving overall surgical outcomes and recovery. For example, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons organization, liposuction remained the most frequently performed cosmetic surgery in 2023 with 347,782 procedures, reflecting a 7% increase from 2022, while tummy tuck procedures rose by 5% to 170,110 cases. Consequently, the rising number of cosmetic surgeries is strengthening growth prospects for the fibrin sealants market.
Leading companies operating in the fibrin sealants market are focusing on developing innovative solutions, such as fibrin sealants, to improve hemostasis, reduce surgical complications, enhance wound healing, and support patient recovery. Fibrin sealants are biological adhesives derived from blood components that replicate the final steps of natural clot formation. For example, in October 2024, Grifols S.A., a Spain-based biopharmaceutical company, received FDA approval for its fibrin sealant for treating surgical bleeding in pediatric patients. The product supports precise hemostasis, reduces postoperative complications, and can be used across a variety of surgical settings.
In July 2024, Corza Medical, a US-based manufacturer of advanced surgical technologies, acquired Takeda's TachoSil manufacturing operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to improve service levels and enhance global customer support. Takeda is a Japan-based pharmaceutical company involved in the development and production of fibrin sealants.
Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc
North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fibrin Sealants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses fibrin sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for fibrin sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fibrin sealants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.